Dr. Jacques Michael Casparian , MD
Dermatology โข Amarillo, TX
6010 Amarillo Blvd W
Amarillo, TX 791061991
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on May 1, 2006; this date does not establish years in practice.
-
Published CMS data list 345 Original Medicare Part B services in 2023.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2023. Published rows only; this is not a quality measure.
-
Published Part B service records, 2023:
- 99213 โ Established patient outpatient office visit: 69 service units.
- 99214 โ Established patient outpatient office visit: 52 service units.
- 11102 โ Biopsy of related skin growth, first growth: 43 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2023. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2022 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2023). CPT notice
See all 11 records in the table ยท Guide: How to read Medicare Part B data
-
Medicare Part B services went from 212 in 2022 to 345 in 2023.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2022โ2023.
Practice Location & Contact Primary Location
6010 Amarillo Blvd W
Amarillo, TX 791061991
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
180 people with Original Medicare in 2023
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2023.
Medicare-allowed amount
About $27,557 in 2023
The total amount Medicare approved for these services in 2023. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2023.
Paid by Medicare
About $17,769 in 2023
The part of the Medicare-allowed amount that Medicare itself paid in 2023, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2023.
Open Payments general payments, program year 2023
All general payments: $839.62 across 37 records.
By nature of payment
- Food and Beverage: $739.63 across 36 records.
- Education: $99.99 across 1 record.
Reporting-company totals (3 largest of 12)
- Janssen Pharmaceuticals, Inc: $226.11 across 7 records.
- ABBVIE INC.: $204.02 across 12 records.
- Sanofi and Genzyme US Companies: $73.98 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2023 (published June 30, 2026).
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Amarillo and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B
Comparisons use 2024 data. The latest CMS data for Dr. Casparian are from 2023.
9 active clinicians are listed under Dermatology with a practice address in Amarillo, TX (1,192 in Texas).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 63% from 212 in 2022 to 345 in 2023.
- 2022: 212
- 2023: 345
-
Medicare-allowed amount
Medicare-allowed amount increased 42% from $19,445 in 2022 to $27,557 in 2023.
- 2022: $19,445
- 2023: $27,557
-
Paid by Medicare
Paid by Medicare increased 18% from $15,017 in 2022 to $17,769 in 2023.
- 2022: $15,017
- 2023: $17,769
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $24.32 in 2021 to $839.62 in 2023.
- 2021: $24.32
- 2022: $1,116.81
- 2023: $839.62
Sources: CMS Medicare Physician & Other Practitioners (2023), CMS Open Payments (2023), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2023 (payments made January 1 โ December 31, 2023): 37 records totaling $839.62.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Janssen Pharmaceuticals, Inc |
Education
In-kind items and services
|
TREMFYA | General | $99.99 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $33.69 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
Otezla | General | $30.40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
SPEVIGO | General | $29.34 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $28.30 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TREMFYA | General | $27.63 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $26.96 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
Otezla | General | $26.65 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $26.64 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ADBRY | General | $25.00 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $24.59 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $24.51 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TREMFYA | General | $24.27 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
REMICADE | General | $23.37 |
| Blueprint Medicines Corporation |
Food and Beverage
In-kind items and services
|
โ | General | $23.36 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $23.19 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $22.83 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $22.75 |
| Biofrontera Inc. |
Food and Beverage
Cash or cash equivalent
|
AMELUZ | General | $21.78 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TREMFYA | General | $21.35 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $21.26 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
LIBTAYO | General | $20.83 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
TALTZ | General | $20.51 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TREMFYA | General | $20.48 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $20.40 |
(top 25 shown)
Source: CMS Open Payments, program year 2023, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2021โ2022 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2022โ2023; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
69 | 68 | $230.00 | $86.94 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
52 | 48 | $330.00 | $122.98 |
|
11102
Biopsy of related skin growth, first growth
|
43 | 43 | $266.06 | $93.73 |
|
17003
Destruction of precancer skin growth, 2-14 growths
|
40 | 12 | $16.57 | $6.49 |
|
11103
Biopsy of related skin growth, each additional growth
|
38 | 19 | $135.21 | $48.58 |
|
17000
Destruction of precancer skin growth, 1 growth
|
25 | 24 | $168.36 | $49.25 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
19 | 19 | $425.00 | $159.57 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
18 | 18 | $285.00 | $102.02 |
|
17110
Destruction of skin growth, 1-14 growths
|
14 | 14 | $290.49 | $101.32 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
14 | 14 | $145.00 | $51.18 |
|
69100
Biopsy of ear
|
13 | 11 | $253.85 | $60.98 |
Source: CMS Part B by Provider and Service, 2023; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2025-10-10NUCC Taxonomy Code: 207N00000X
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
NUCC Taxonomy Code: 207ND0101X
The highly-trained surgeons that perform Mohs Micrographic Surgery are specialists both in dermatology and pathology. With their extensive knowledge of the skin and unique pathological skills, they are able to remove only diseased tissue, preserving healthy tissue and minimizing the cosmetic impact of the surgery. Mohs surgeons who belong to the American College of Mohs Surgery (ACMS) have completed a minimum of one year of fellowship training at one of the ACMS-approved training centers in the U.S.
NUCC Taxonomy Code: 207NS0135X
Procedural Dermatology, a subspecialty of Dermatology, encompassing a wide variety of surgical procedures and methods to remove or modify skin tissue for health or cosmetic benefit. These methods include scalpel surgery, laser surgery, chemical surgery, cryosurgery (liquid nitrogen), electrosurgery, aspiration surgery, liposuction, injection of filler substances, and Mohs micrographic controlled surgery (a special technique for the removal of growths, especially skin cancers).
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Social Worker - Clinical
Licensed Clinical Social Worker
Anesthesiology
Doctor of Medicine (M.D.)
Nurse Practitioner - Gerontology
Nurse Practitioner
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 6010 AMARILLO BLVD W, AMARILLO, TX 791061991 (Tel: 8063559703)
Registered at 6010 AMARILLO BLVD W, AMARILLO, TX 791061991 (Tel: 8063559703)
Dermatology (license number reported to NPPES: KS 0425322)
Registered at 1793 13TH ST SE, SALEM, OR 973022541 (Tel: 5033628385)
Registered at 1793 13TH ST SE, SALEM, OR 973022541 (Tel: 5033628385)
Dermatology (license number reported to NPPES: KS 0425322)
NPI status registered as active in NPPES database
Registered at 4101 S 4TH ST, LEAVENWORTH VA HOSPITAL, LEAVENWORTH, KS 660485014 (Tel: 9136822000)
Registered at LEAVENWORTH VAMC, 4101 S. 4TH ST. TRAFFICWAY, LEAVENWORTH, KS 66048 (Tel: 9136822000)
Recorded as JACQUES CASPARIAN, M.D.
Dermatology (license number reported to NPPES: KS 0425322)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Dermatology Specialists in Amarillo
- Dr. Elaine Cook, MD
- Dr. Scott Miller, MD
- Dr. James Yeary, MD
- Dr. Edward Mccarthy, MD
- Dr. Tyler Enos, MD
- Dr. Jason Jones, MD
Mailing Address
6010 Amarillo Blvd W
Amarillo, TX 791061991
Phone: 8063559703